Search

Adam L Feire

from Hull, MA
Age ~45
Get Report
Also known as:
Adam Fiere, Adam Fire
Phone and address:
22 Bradford Ave, Nantasket Beach, MA 02045
Related to:
Michael Feire, 74
Connected to:
Mark A Feireisel, 47John D Feirick, 56Merry J Feirick, 53Janell D Feiring, 60Allegra S Feiro, 27Alicia E Feis, 43Robert A Feis, 56Helmut Feischl, 57Kevin C Feisel, 63Debra J Feisley, 66

Adam Feire Phones & Addresses

  • 22 Bradford Ave, Hull, MA 02045
  • 19 Essex St, Charlestown, MA 02129 (617) 337-5643
  • Boston, MA
  • San Francisco, CA
  • Cambridge, MA
  • Madison, WI
  • Oakdale, NY
  • Harrisonburg, VA
  • 33 Soley St #1, Charlestown, MA 02129 (617) 337-5643

Work

Company: Novartis institutes for biomedical research (nibr) Feb 2020 Position: Head of search and evaluation, north america, business development and licensing

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of Wisconsin - Madison 2001 to 2005 Specialities: Molecular Biology

Skills

Drug Discovery • Virology • Infectious Diseases • Pharmaceutical Industry • Drug Development • Antibodies • Biotechnology • Biologics • Molecular Biology • Assay Development • Biochemistry • Cell Biology • Vaccines • Immunology • Biomarker Discovery • High Throughput Screening

Industries

Pharmaceuticals

Resumes

Resumes

Adam Feire Photo 1

Head Of Search And Evaluation, North America, Business Development And Licensing

View page
Location:
22 Bradford Ave, Hull, MA 02045
Industry:
Pharmaceuticals
Work:
Novartis Institutes For Biomedical Research (Nibr)
Head of Search and Evaluation, North America, Business Development and Licensing
Education:
University of Wisconsin - Madison 2001 - 2005
Doctorates, Doctor of Philosophy, Molecular Biology James Madison University 1997 - 2001
Bachelors, Bachelor of Science, Biology
Skills:
Drug Discovery
Virology
Infectious Diseases
Pharmaceutical Industry
Drug Development
Antibodies
Biotechnology
Biologics
Molecular Biology
Assay Development
Biochemistry
Cell Biology
Vaccines
Immunology
Biomarker Discovery
High Throughput Screening

Publications

Us Patents

Polyomavirus Neutralizing Antibodies

View page
US Patent:
20220363735, Nov 17, 2022
Filed:
Oct 15, 2021
Appl. No.:
17/502910
Inventors:
- Basel, CH
Zorica DRAGIC - Basel, CH
Adam Lloyd FEIRE - Hull MA, US
Mark KNAPP - Oakland CA, US
Steven KOVACS - Randolph NJ, US
Elisabetta TRAGGIAI - Basel, CH
Lichun WANG - Shanghai, CN
Yongqiang WANG - Shanghai, CN
Danqing WU - Shanghai, CN
Qilong WU - Shanghai, CN
Fangmin Xu - Belmont MA, US
Assignee:
Novartis AG - Basel
International Classification:
C07K 16/08
A61K 39/42
A61K 45/06
A61K 9/19
Abstract:
The present invention relates to anti-VP 1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

Polyomavirus Neutralizing Antibodies

View page
US Patent:
20200190167, Jun 18, 2020
Filed:
Oct 18, 2019
Appl. No.:
16/657855
Inventors:
- Basel, CH
Zorica DRAGIC - Basel, CH
Adam Lloyd FEIRE - Hull MA, US
Mark KNAPP - Oakland CA, US
Steven KOVACS - Randolph NJ, US
Elisabetta TRAGGIAI - Basel, CH
Lichun WANG - Shanghai, CN
Yongqiang WANG - Shanghai, CN
Danqing WU - Shanghai, CN
Qilong WU - Shanghai, CN
Fangmin Xu - Belmont MA, US
International Classification:
C07K 16/08
A61K 39/42
A61K 45/06
A61K 9/19
Abstract:
The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

Polyomavirus Neutralizing Antibodies

View page
US Patent:
20190071488, Mar 7, 2019
Filed:
Nov 7, 2018
Appl. No.:
16/183262
Inventors:
- Basel, CH
Zorica DRAGIC - Basel, CH
Adam Lloyd FEIRE - Hull MA, US
Mark KNAPP - Oakland CA, US
Steven KOVACS - Randolph NJ, US
Elisabetta TRAGGIAI - Basel, CH
Lichun WANG - Shanghai, CN
Yongqiang WANG - Shanghai, CN
Danqing WU - Shanghai, CN
Qilong WU - Shanghai, CN
Fangmin XU - Belmont MA, US
International Classification:
C07K 16/08
A61K 45/06
A61K 39/42
Abstract:
The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

Polyomavirus Neutralizing Antibodies

View page
US Patent:
20190002533, Jan 3, 2019
Filed:
Sep 8, 2016
Appl. No.:
15/758491
Inventors:
Johanna ABEND - Emeryville CA, US
Zorica DRAGIC - Basel, CH
Adam Lloyd FEIRE - Hull MA, US
Mark KNAPP - Oakland CA, US
Steven KOVACS - Randolph NJ, US
Elisabetta TRAGGIAI - Basel, CH
Lichun WANG - Shanghai, CN
Yongqiang WANG - Shanghai, CN
Danqing WU - Shanghai, CN
Qilong WU - Shanghai, CN
Fangmin XU - Belmont MA, US
International Classification:
C07K 16/08
A61K 9/19
A61K 39/42
A61K 45/06
Abstract:
The present disclosure is directed to anti-VP1 antibodies, antibody fragments, and their uses for the reducing the likelihood or treatment of polyoma virus infection.

Polyomavirus Neutralizing Antibodies

View page
US Patent:
20180079799, Mar 22, 2018
Filed:
Dec 1, 2017
Appl. No.:
15/829115
Inventors:
- Basel, CH
Zorica DRAGIC - Basel, CH
Adam Lloyd FEIRE - Hull MA, US
Mark KNAPP - Oakland CA, US
Steven KOVACS - Randolph NJ, US
Elisabetta TRAGGIAI - Basel, CH
Lichun WANG - Shanghai, CN
Yongqiang WANG - Shanghai, CN
Danqing WU - Shanghai, CN
Qilong WU - Shanghai, CN
Fangmin XU - Belmont MA, US
International Classification:
C07K 16/08
A61K 45/06
A61K 39/42
Abstract:
The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

Polyomavirus Neutralizing Antibodies

View page
US Patent:
20170088605, Mar 30, 2017
Filed:
Sep 7, 2016
Appl. No.:
15/258925
Inventors:
Johanna ABEND - Emeryville CA, US
Zorica DRAGIC - Basel, CH
Adam Lloyd FEIRE - Hull MA, US
Mark KNAPP - Oakland CA, US
Steven KOVACS - Randolph NJ, US
Elisabetta TRAGGIAI - Basel, CH
Lichun WANG - Shanghai, CN
Yongqiang WANG - Shanghai, CN
Danqing WU - Shanghai, CN
Qilong WU - Shanghai, CN
Fangmin XU - Belmont MA, US
Assignee:
Novartis AG - Basel
International Classification:
C07K 16/08
A61K 45/06
A61K 39/42
Abstract:
The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

Cytomegalovirus Disintegrin-Like Peptides

View page
US Patent:
20150104466, Apr 16, 2015
Filed:
Oct 16, 2013
Appl. No.:
14/055299
Inventors:
- MADISON WI, US
Adam L. Feire - Charlestown MA, US
Assignee:
WISCONSIN ALUMNI RESEARCH FOUNDATION - MADISON WI
International Classification:
C07K 16/08
US Classification:
4241591, 5303894, 5303883, 435375, 514 37, 5303879, 530326
Abstract:
The present invention relates to methods and compositions for inhibiting the entry of viruses, such as herpesviruses into a host cell. A conserved viral integrin-binding gB disintegrin-like domain has been identified that engages integrins and facilitates viral internalization into the host cell. Therefore, methods and compositions, such as antiviral agents encompassing the conserved gB disintegrin-like domain and antibodies thereto are described. These active agents interfere with the interaction between virions and cellular integrins, thereby inhibiting viral infection of a host cell.

Antiviral Activity Of Tyrosine Kinase Inhibitors Against Hepatitus C Virus

View page
US Patent:
20140127157, May 8, 2014
Filed:
Nov 4, 2013
Appl. No.:
14/071451
Inventors:
Erica Canino - Alameda CA, US
Adam Feire - Madison WI, US
Christopher Jones - Basel, CH
Paul W. Manley - Basel, CH
International Classification:
A61K 31/506
A61K 31/517
A61K 31/5377
A61K 38/21
A61K 31/496
A61K 31/404
A61K 31/7056
A61K 31/5025
A61K 31/4412
US Classification:
424 854, 514275, 51425505, 514248, 5142664, 5142345, 514346, 5142531, 514414, 514 43
Abstract:
Antiviral activity of Nilotinib against Hepatitis C virus.
Control profile
Adam L Feire from Hull, MA, age ~45 Get Report